Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml

被引:43
作者
Kumar, Virendra
Jagannathan, N. R. [1 ]
Kumar, Rajeev
Thulkar, Sanjay
Gupta, S. Dutta
Hemal, A. K.
Gupta, N. P.
机构
[1] All India Inst Med Sci, Dept NMR, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Urol, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Radiodiag, New Delhi 110029, India
[4] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
关键词
magnetic resonance spectroscopic imaging; magnetic resonance imaging; prostate cancer; prostate specific antigen; transrectal ultrasound biopsy; digital rectal examination;
D O I
10.1002/nbm.1083
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Results of the evaluation of transrectal ultrasound (TRUS) guided needle biopsy of voxels identified as suspicious of malignancy on magnetic resonance spectroscopic imaging (MRSI) in a large cohort of men (n-93) with abnormal digital rectal examination (DRE) [prostate specific antigen (PSA) 0-4 ng/ml] or PSA less than 10 ng/ml, are reported. Three-dimensional H-1 MRSI was carried out at 1.5 T using a pelvic-phased array coil in combination with an endorectal surface coil. Voxels were classified as suspicious of malignancy based on Cit/(Cho + Cr) metabolite ratio. TRUS-guided biopsy of suspicious voxels was performed using the z- and x-coordinates obtained from MR images and two to three cores were taken from the suspected site. A systematic sextant biopsy was also carried out. MRSI showed voxels suspicious of malignancy in 44 patients while biopsy revealed cancer in 11 patients (25%). Patients who were negative for malignancy on MRSI were also negative on biopsy. An overall sensitivity of 100%, specificity of 54%, negative predictive value of 100% and accuracy of 60% were obtained. The site of biopsy was confirmed (n = 20) as a hypo-intense area on repeat MRI while repeat MRSI revealed high choline and low citrate. The overall success rate of MRI-directed TRUS-guided biopsy of 25% was higher compared with a 9% success rate achieved without MR guidance in another group of 120 patients. Our results indicate that TRUS-guided biopsy of suspicious area identified as malignant from MRSI can be performed using the coordinates of the voxel derived from MR images. This increases the detection rate of prostate cancer in men with PSA level <10 ng/ml or abnormal DRE and also demonstrates the potential of MR in routine clinical practice. Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 49 条
[1]   Negative prostatic biopsies in patients with a high risk of prostate cancer -: Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool?: A preliminary study [J].
Amsellem-Ouazana, D ;
Younes, P ;
Conquy, S ;
Peyromaure, M ;
Flam, T ;
Debré, B ;
Zerbib, M .
EUROPEAN UROLOGY, 2005, 47 (05) :582-586
[2]   A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy [J].
Babaian, RJ ;
Toi, A ;
Kamoi, K ;
Troncoso, P ;
Sweet, J ;
Evans, R ;
Johnston, D ;
Chen, M .
JOURNAL OF UROLOGY, 2000, 163 (01) :152-157
[3]   MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: Initial results [J].
Beyersdorff, D ;
Winkel, A ;
Hamm, B ;
Lenk, S ;
Loening, SA ;
Taupitz, M .
RADIOLOGY, 2005, 234 (02) :576-581
[4]   Prostate cancer: Evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - Initial experience [J].
Buckley, DL ;
Roberts, C ;
Parker, GJM ;
Logue, JP ;
Hutchinson, CE .
RADIOLOGY, 2004, 233 (03) :709-715
[5]  
CARTER HB, 2002, DIAGNOSIS STAGING PR, P3055
[6]   Optimization of prostate biopsy strategy using computer based analysis [J].
Chen, ME ;
Troncoso, P ;
Johnston, DA ;
Tang, K ;
Babaian, RJ .
JOURNAL OF UROLOGY, 1997, 158 (06) :2168-2175
[7]   Magnetic resonance imaging and spectroscopic imaging of prostate cancer [J].
Coakley, FV ;
Qayyum, A ;
Kurhanewicz, J .
JOURNAL OF UROLOGY, 2003, 170 (06) :S69-S75
[8]   Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer [J].
DiBiase, SJ ;
Hosseinzadeh, K ;
Gullapalli, RP ;
Jacobs, SC ;
Naslund, MJ ;
Sklar, GN ;
Alexander, RB ;
Yu, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :429-438
[9]   Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging [J].
Engelbrecht, MR ;
Huisman, HJ ;
Laheij, RJF ;
Jager, GJ ;
van Leenders, GJLH ;
Hulsbergen-Van De Kaa, CA ;
de la Rosette, JJMCH ;
Blickman, JG ;
Barentsz, JO .
RADIOLOGY, 2003, 229 (01) :248-254
[10]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36